Infection-related complications in patients with end stage renal failure dialyzed through a permanent catheter
Abstract
Objectives Progression of renal failure leads to an increase in the number of patients who require forming dialysis access. Old age and a rising morbidity make it impossible to form a native arteriovenous fistula and a permanent catheter becomes the first choice. The presence of a catheter frequently generates complications, including infections, which may result in a higher mortality rate. Patients and methods A retrospective analysis data has been conducted, involving 398 patients who had permanent catheters implanted from 2010 to 2016. Out of this group, 65 patients who suffered infection-related complications have been identified. Risk factors for infection and a survival rate of the population have been estimated. Results Between 2010 and 2016, 495 catheters were implanted for 398 patients aged 68.73(13.26) years on average. 92 catheter-related infections (23.1%) were recorded in 65 patients. A higher risk of infection has been noted among younger patients, with coronary disease and heart failure. Patients affected by infection had 35.38% survivability as against 38.14% for those with no infection: p= 0.312. A higher mortality risk was identified among patients suffering catheter-related infections with cardiac implants and vascular prostheses. Unfavourable prognosis was for infections occurring together with hypotension, high leucocytosis, a low number of platelets and a high leukocyte/platelet ratio. Conclusion Dialysis patients who use permanent catheters run a high risk of infection-related complications, especially younger patients suffering from coronary conditions and heart failure. Severe catheter-related infections lead to a high mortality rate, therefore it is necessary to limit this form of access.
Keywords: end-stage renal diseasepermanent dialysis catheterrisk of infection-related complicationsdeath risk
References
- Brala M, et al. Kamiński R. Trudnowski S. Long-term complications after implantation of catheters for hemodialysis. Geriatrics. 2014; 8: 1–5.
- Załuska W, Klinger M, Kusztal M, et al. Recommendations of the Working Group of the Polish Society of Nephrology for the criteria of quality treatment in dialysis patients with end-stage renal disease. Nefrol Dial Pol . 2015; 919 : 6–11.
- Weyde W, Krajewska M, Klinger M. Vascular access for hemodialysis. Polish Nefrol Forum. 2008; 1(3): 119–126.
- Polkinghorne KR, McDonald SP, Atkins RC, et al. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol. 2004; 15(2): 477–486.
- O'Grady NP, Alexander M, Burns LA, et al. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011; 52(9): e162–e193.
- Maczyńska B, Przondo-Mordarska A. Bloodstream infections related to venous access. Zakażenia . 2011; 11(4): 107–116.
- Lin KY, Cheng A, Chang YC, et al. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care. J Microbiol Immunol Infect. 2017; 50(3): 339–348.
- Haddadin Y. Regunath H. Central Line Associated Blood Stream Infections (CLABSI). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019.
- El Minschawy. Evaluation of vascular access complications in acute and chronic hemodialysis; The Journal of Vascular Access. 2004; 5(2): 76–82.
- Fysaraki M, Samonis G, Valachis A, et al. Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int J Med Sci. 2013; 10(12): 1632–1638.
- Knezevic V, Durdević-Micković T, Bozić D. Risk factors for catheter-related infections in patients on hemodialysis. Vojnosanit Pregl . 2018; 75(2): 159–166.
- Lemaire X, Morena M, Leray-Moragués H, et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif. 2009; 28(1): 21–28.
- Delistefani F, Wallbach M, Müller GA, et al. Risk factors for catheter-related infections in patients receiving permanent dialysis catheter. BMC Nephrol. 2019; 20(1): 199.
- Silva TNV, Mendes ML, Abrão JMG, et al. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin. Int Urol Nephrol. 2013; 45(5): 1405–1413.
- Thompson S, Wiebe N, Klarenbach S, et al. Alberta Kidney Disease Network. Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study. BMC Nephrol. 2017; 18(1): 357.
- Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006; 81(9): 1159–1171.
- Murea M, James KM, Russell GB, et al. Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Clin J Am Soc Nephrol. 2014; 9(4): 764–770.
- Milaniuk A, Stefanowicz J. Central venous catheter and the risk of catheter associated bloodstream infection in young oncological patient. Ann Acad Med Gedan. 2015; 45: 19–33.
- National Healthcare Safety Network (NHSN, Report, CDC). https://www.cdc.gov/nhsn/datastat/index.html.
- Resić H, Ajanović S, Kukavica N, et al. [Tunneled catheter infections in patients on hemodialysis--one center experience]. Acta Med Croatica. 2012; 66 Suppl 2: 17–21.
- Lima JK, Lima SR, de Lima AL, et al. Double-lumen catheter in the right jugular vein induces two sub-endothelial abscesses in an unusual place, the transition between the superior vena cava and the right atrium: a case report. Int Arch Med. 2014; 7: 37.
- Maczyńska B, Smutnicka D, Przondo-Mordarska A. Biofilm formation by clinical Klebsiella strains expressing various types of adhesins on chemically different catheters. Adv Clin Exp Med. 2010; 19(2): 95–104.
- Wolska K, Jakubczak A. Detection of Pseudomonas aeruginosa biofilm on medical biomaterials. Medycyna doświadczalna i mikrobiologia . 2003; 55(4): 371–378.
- Kusztal M, Nowak K. Cardiac implantable electronic device and vascular access: Strategies to overcome problems. J Vasc Access. 2018; 19(6): 521–527.
- Saad TF, Ahmed W, Davis K, et al. Cardiovascular implantable electronic devices in hemodialysis patients: prevalence and implications for arteriovenous hemodialysis access interventions. Semin Dial. 2015; 28(1): 94–100.
- Bray BD, Boyd J, Daly C, et al. Scottish Renal Registry. Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patients. QJM. 2012; 105(11): 1097–1103.
- Yaprak M, Turan MN, Dayanan R, et al. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients. Int Urol Nephrol. 2016; 48(8): 1343–1348.
- Lai NM, Chaiyakunapruk N, Lai NAn, et al. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev. 2016; 3: CD007878.
- Oun HA, Price AJ, Traynor JP. Infective endocarditis in patients on haemodialysis - possible strategies for prevention. Scott Med J. 2016; 61(2): 97–102.
- Camins BC. Prevention and treatment of hemodialysis-related bloodstream infections. Semin Dial. 2013; 26(4): 476–481.
- Valencia VC, Cruz CO, Rodríguez OM, et al. Inflamación en hemodiálisis y su correlación con los índices neutrófilos/linfocitos y plaquetas/linfocitos. Nefrología. 2017; 37(5): 554–556.
- Catabay C, Obi Y, Streja E, et al. Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients. Am J Nephrol. 2017; 46(5): 408–416.
- Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013; 17(3): 391–396.